We want to reduce the
transmission of resistant bacteria
in neonatal intensive care units
across Europe and globally.

We want to reduce the
transmission of resistant bacteria

in neonatal intensive care units
across Europe and globally

Why this project

Nearly 1 in 10 newborns in Europe is admitted to a neonatal intensive care unit in the first days of life – that is around 400,000 admissions every year.

While care in a neonatal unit results in a greater chance of survival in newborns with serious illness, it also increases the risk of exposure to bacteria from the hospital environment. These can cause serious infections in babies, which are commonly resistant to many routinely used antibiotics.

The NeoIPC response

NeoIPC will investigate the effectiveness of optimised kangaroo care in preventing transmission of and infection with hospital bacteria in hospitalised newborns.

But what is kangaroo care and what are some of its benefits, according to the WHO? Watch the video to find out.

 

Learn about kangaroo care

Hospital-acquired infection surveillance

Within the framework of the NeoIPC project, we have developed a surveillance system for NICUs to contribute to the prevention and control of healthcare-associated infections in neonatology.

Join our surveillance activities
Access the NeoIPC surveillance toolkit

Governance

Led by the University of Padova, NeoIPC project consists of fourteen partners representing multiple institutions in Europe and Africa.

Latest project news

View all